CA2353693A1 - Compositions pharmaceutiques contenant du citaloprame - Google Patents

Compositions pharmaceutiques contenant du citaloprame Download PDF

Info

Publication number
CA2353693A1
CA2353693A1 CA002353693A CA2353693A CA2353693A1 CA 2353693 A1 CA2353693 A1 CA 2353693A1 CA 002353693 A CA002353693 A CA 002353693A CA 2353693 A CA2353693 A CA 2353693A CA 2353693 A1 CA2353693 A1 CA 2353693A1
Authority
CA
Canada
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002353693A
Other languages
English (en)
Other versions
CA2353693C (fr
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2353693(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2353693A1 publication Critical patent/CA2353693A1/fr
Application granted granted Critical
Publication of CA2353693C publication Critical patent/CA2353693C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002353693A 2000-08-10 2001-07-24 Compositions pharmaceutiques contenant du citaloprame Expired - Lifetime CA2353693C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
CA2353693A1 true CA2353693A1 (fr) 2002-01-22
CA2353693C CA2353693C (fr) 2003-07-22

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002353693A Expired - Lifetime CA2353693C (fr) 2000-08-10 2001-07-24 Compositions pharmaceutiques contenant du citaloprame

Country Status (34)

Country Link
EP (1) EP1318805A2 (fr)
JP (1) JP2003531153A (fr)
KR (1) KR20030024833A (fr)
CN (1) CN1446089A (fr)
AR (1) AR030095A1 (fr)
AT (1) AT5744U1 (fr)
AU (2) AU2001100198B4 (fr)
BE (1) BE1013559A6 (fr)
BG (1) BG107578A (fr)
BR (1) BR0113250A (fr)
CA (1) CA2353693C (fr)
CH (2) CH694242A5 (fr)
CZ (1) CZ2003397A3 (fr)
DE (2) DE10139115A1 (fr)
EA (1) EA200300247A1 (fr)
ES (1) ES2172481B2 (fr)
FI (1) FI5176U1 (fr)
FR (1) FR2812811B1 (fr)
GB (1) GB2368014B (fr)
GR (1) GR1004193B (fr)
HR (1) HRP20030054A2 (fr)
HU (1) HUP0103071A3 (fr)
IE (1) IES20010693A2 (fr)
IL (1) IL154050A0 (fr)
IS (1) IS6021A (fr)
IT (1) ITMI20011637A1 (fr)
MX (1) MXPA03000837A (fr)
NL (1) NL1018741C1 (fr)
NO (1) NO20013891L (fr)
NZ (1) NZ523785A (fr)
PL (1) PL359824A1 (fr)
SK (1) SK2842003A3 (fr)
WO (1) WO2001080619A2 (fr)
YU (1) YU9003A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
WO2004103361A2 (fr) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Forme posologique pharmaceutique de citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (fr) * 2004-10-05 2006-04-13 Strides Acrolab Limited Systeme ameliore d’administration de medicaments a base de bromhydrate de citalopram et processus de production dudit systeme
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2446847B (en) * 2007-02-02 2012-02-22 Ubiquisys Ltd Location of Basestation
WO2017020841A1 (fr) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 Composition pharmaceutique contenant du lcz696 et son procédé de préparation
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (fr) * 1994-11-28 1997-01-15 Lilly Co Eli Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
ITMI20011637A1 (it) 2003-01-27
YU9003A (sh) 2006-05-25
DE10139115A1 (de) 2002-03-28
ITMI20011637A0 (it) 2001-07-27
HRP20030054A2 (en) 2005-02-28
GB0118579D0 (en) 2001-09-19
HUP0103071A2 (hu) 2002-05-29
CH694242A5 (de) 2004-10-15
AT5744U1 (de) 2002-11-25
GB2368014B (en) 2004-06-23
HUP0103071A3 (en) 2002-12-28
GB2368014A (en) 2002-04-24
AU2001100198A4 (en) 2001-08-16
NO20013891L (no) 2002-02-11
IES20010693A2 (en) 2002-07-10
BE1013559A6 (fr) 2002-03-05
FI5176U1 (fi) 2001-12-27
SK2842003A3 (en) 2003-09-11
PL359824A1 (en) 2004-09-06
FR2812811A1 (fr) 2002-02-15
MXPA03000837A (es) 2003-06-06
CA2353693C (fr) 2003-07-22
ES2172481A1 (es) 2002-09-16
IS6021A (is) 2001-10-20
BG107578A (bg) 2003-09-30
DE20113195U1 (de) 2001-11-15
IL154050A0 (en) 2003-07-31
NO20013891D0 (no) 2001-08-09
NL1018741C1 (nl) 2002-02-12
KR20030024833A (ko) 2003-03-26
WO2001080619A3 (fr) 2002-02-21
CZ2003397A3 (cs) 2003-06-18
AR030095A1 (es) 2003-08-13
WO2001080619A2 (fr) 2001-11-01
CH694241A5 (de) 2004-10-15
EA200300247A1 (ru) 2003-06-26
AU2001100198B4 (en) 2002-06-13
AU2001279591A1 (en) 2001-11-07
BR0113250A (pt) 2003-06-24
JP2003531153A (ja) 2003-10-21
HU0103071D0 (en) 2001-10-28
CN1446089A (zh) 2003-10-01
EP1318805A2 (fr) 2003-06-18
NZ523785A (en) 2004-09-24
ES2172481B2 (es) 2004-08-01
FR2812811B1 (fr) 2006-08-18
GR1004193B (el) 2003-03-24
GR20010100377A (el) 2002-09-06

Similar Documents

Publication Publication Date Title
CA2326517A1 (fr) Nouvelles formes galeniques de meloxicame a administrer par voie orale
CA2382098A1 (fr) Formes de presentation pharmaceutiques orales a action retardee
CA2427815A1 (fr) Preparations d'hydrocodone a liberation lente
CA2353693A1 (fr) Compositions pharmaceutiques contenant du citaloprame
CA2339991A1 (fr) Microemulsions comme formes pharmaceutiques solides destinees a une administration orale
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
DE69620606T2 (de) Feste oral anzuwendende arzeneiform
CA2159580A1 (fr) Compositions pharmaceutiques renfermant la polyvinylpyrrolidone et un tri-ester; methode de preparation
WO2007009806A3 (fr) Formulations posologiques solides de medicaments narcotiques presentant une adsorption buccale amelioree
CA2182004C (fr) Comprimes enrobes de paracetamol et de domperidone
RU2003100507A (ru) Фармацевтические композиции
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
CA2445519A1 (fr) Procede permettant de preparer une composition pharmaceutique faiblement dosee, a repartition et a activite uniformes du medicament
WO2002024203A3 (fr) Formulation à administrer oralement à libération contrôlée
CA2432177A1 (fr) Medicaments pour la prevention et/ou la therapie de l'endometriose
HRP20000291B1 (en) High purity (1r, 2s, 4r)-(-)-2-/(2'-/n,n-dimethylamino/-ethoxy)/-2-/phenyl/-1,7,7-tri-/methyl/bicyclo/2.2.1/ heptane and pharmaceutically acceptable acid addition salts thereof and process for the preparation of these compounds as well medicaments containing one or more of them and the use thereof
WO2005013935A3 (fr) Nouvelle composition
JP2002538207A5 (fr)
JP2005525391A5 (fr)
YU54503A (sh) Farmaceutski sastav koji sadrži citalopram
WO2005004836A3 (fr) Forme dosifiee orale de mesylate de saquinavir
EA200101108A1 (ru) Полиморфные модификации кристаллического цитрата азабицикло[2.2.2]октан-3-амина и их фармацевтические композиции
CA2423288A1 (fr) Nouvelles compositions pharmaceutiques contenant de l'epinastine et de la pseudoephedrine
RU2002126216A (ru) Фармацевтическая композиция для лечения и профилактики фиброза и цирроза печени

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210726